Article
FLT3 inhibition upregulates OCT4/NANOG to promote proliferation and TKI resistance of FLT3-ITD+ acute myeloid leukemia
2024-04-29
Abstract excerpt
<title>Abstract</title> <p><italic>Background: </italic>Up to 30% of acute myeloid leukemia (AML) patients face unfavorable outcomes due to the FMS-like receptor tyrosine kinase-3 (FLT3) internal tandem duplication (ITD) mutation. Although FLT3 inhibitors show encouraging outcomes in treatment, they fail to eliminate leukemia stem cells, the origin of persistent and resistant lesions. Exploration of the mechanism...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f5f8e4cd-2414-52d6-9518-d878ba33131c
- DOI
- 10.21203/rs.3.rs-4310376/v1
